Last reviewed · How we verify
B2065
At a glance
| Generic name | B2065 |
|---|---|
| Sponsor | Tasly Pharmaceutical Group Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- B2065 CI brief — competitive landscape report
- B2065 updates RSS · CI watch RSS
- Tasly Pharmaceutical Group Co., Ltd portfolio CI